Cargando…
An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning
(1) Background: People living with type 1 diabetes (T1D) require self-management to maintain blood glucose (BG) levels in a therapeutic range through the delivery of exogenous insulin. However, due to the various variability, uncertainty and complex glucose dynamics, optimizing the doses of insulin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570884/ https://www.ncbi.nlm.nih.gov/pubmed/32899979 http://dx.doi.org/10.3390/s20185058 |
_version_ | 1783597050123780096 |
---|---|
author | Zhu, Taiyu Li, Kezhi Kuang, Lei Herrero, Pau Georgiou, Pantelis |
author_facet | Zhu, Taiyu Li, Kezhi Kuang, Lei Herrero, Pau Georgiou, Pantelis |
author_sort | Zhu, Taiyu |
collection | PubMed |
description | (1) Background: People living with type 1 diabetes (T1D) require self-management to maintain blood glucose (BG) levels in a therapeutic range through the delivery of exogenous insulin. However, due to the various variability, uncertainty and complex glucose dynamics, optimizing the doses of insulin delivery to minimize the risk of hyperglycemia and hypoglycemia is still an open problem. (2) Methods: In this work, we propose a novel insulin bolus advisor which uses deep reinforcement learning (DRL) and continuous glucose monitoring to optimize insulin dosing at mealtime. In particular, an actor-critic model based on deep deterministic policy gradient is designed to compute mealtime insulin doses. The proposed system architecture uses a two-step learning framework, in which a population model is first obtained and then personalized by subject-specific data. Prioritized memory replay is adopted to accelerate the training process in clinical practice. To validate the algorithm, we employ a customized version of the FDA-accepted UVA/Padova T1D simulator to perform in silico trials on 10 adult subjects and 10 adolescent subjects. (3) Results: Compared to a standard bolus calculator as the baseline, the DRL insulin bolus advisor significantly improved the average percentage time in target range (70–180 mg/dL) from [Formula: see text] to [Formula: see text] ([Formula: see text]) and [Formula: see text] to [Formula: see text] ([Formula: see text]) in the the adult and adolescent cohorts, respectively, while reducing hypoglycemia. (4) Conclusions: The proposed algorithm has the potential to improve mealtime bolus insulin delivery in people with T1D and is a feasible candidate for future clinical validation. |
format | Online Article Text |
id | pubmed-7570884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75708842020-10-28 An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning Zhu, Taiyu Li, Kezhi Kuang, Lei Herrero, Pau Georgiou, Pantelis Sensors (Basel) Article (1) Background: People living with type 1 diabetes (T1D) require self-management to maintain blood glucose (BG) levels in a therapeutic range through the delivery of exogenous insulin. However, due to the various variability, uncertainty and complex glucose dynamics, optimizing the doses of insulin delivery to minimize the risk of hyperglycemia and hypoglycemia is still an open problem. (2) Methods: In this work, we propose a novel insulin bolus advisor which uses deep reinforcement learning (DRL) and continuous glucose monitoring to optimize insulin dosing at mealtime. In particular, an actor-critic model based on deep deterministic policy gradient is designed to compute mealtime insulin doses. The proposed system architecture uses a two-step learning framework, in which a population model is first obtained and then personalized by subject-specific data. Prioritized memory replay is adopted to accelerate the training process in clinical practice. To validate the algorithm, we employ a customized version of the FDA-accepted UVA/Padova T1D simulator to perform in silico trials on 10 adult subjects and 10 adolescent subjects. (3) Results: Compared to a standard bolus calculator as the baseline, the DRL insulin bolus advisor significantly improved the average percentage time in target range (70–180 mg/dL) from [Formula: see text] to [Formula: see text] ([Formula: see text]) and [Formula: see text] to [Formula: see text] ([Formula: see text]) in the the adult and adolescent cohorts, respectively, while reducing hypoglycemia. (4) Conclusions: The proposed algorithm has the potential to improve mealtime bolus insulin delivery in people with T1D and is a feasible candidate for future clinical validation. MDPI 2020-09-06 /pmc/articles/PMC7570884/ /pubmed/32899979 http://dx.doi.org/10.3390/s20185058 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhu, Taiyu Li, Kezhi Kuang, Lei Herrero, Pau Georgiou, Pantelis An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning |
title | An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning |
title_full | An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning |
title_fullStr | An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning |
title_full_unstemmed | An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning |
title_short | An Insulin Bolus Advisor for Type 1 Diabetes Using Deep Reinforcement Learning |
title_sort | insulin bolus advisor for type 1 diabetes using deep reinforcement learning |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7570884/ https://www.ncbi.nlm.nih.gov/pubmed/32899979 http://dx.doi.org/10.3390/s20185058 |
work_keys_str_mv | AT zhutaiyu aninsulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning AT likezhi aninsulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning AT kuanglei aninsulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning AT herreropau aninsulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning AT georgioupantelis aninsulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning AT zhutaiyu insulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning AT likezhi insulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning AT kuanglei insulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning AT herreropau insulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning AT georgioupantelis insulinbolusadvisorfortype1diabetesusingdeepreinforcementlearning |